Mark H Einstein

Summary

Affiliation: Montefiore Medical Center
Country: USA

Publications

  1. ncbi request reprint Clinician's guide to human papillomavirus immunology: knowns and unknowns
    Mark H Einstein
    Division of Gynecologic Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA
    Lancet Infect Dis 9:347-56. 2009
  2. pmc Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy
    Mark H Einstein
    Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York, USA
    J Clin Microbiol 52:2089-95. 2014
  3. pmc Phase II trial of adjuvant pelvic radiation "sandwiched" between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma
    Mark H Einstein
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Bronx, NY, USA
    Gynecol Oncol 124:21-5. 2012
  4. pmc Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years
    Mark H Einstein
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
    Hum Vaccin 7:1343-58. 2011
  5. pmc Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years
    Mark H Einstein
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
    Hum Vaccin 7:1359-73. 2011
  6. ncbi request reprint Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years
    Mark H Einstein
    Montefiore Medical Center, Albert Einstein College of Medicine, Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Bronx, NY, USA
    Hum Vaccin 5:705-19. 2009
  7. pmc Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III
    Mark H Einstein
    Albert Einstein College of Medicine, and Albert Einstein Cancer Center, Bronx, NY 10461, USA
    Gynecol Oncol 106:453-60. 2007
  8. doi request reprint Age-stratified performance of the Cervista HPV 16/18 genotyping test in women with ASC-US cytology
    Mark H Einstein
    Albert Einstein College of Medicine and Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, NY 10461, USA
    Cancer Epidemiol Biomarkers Prev 20:1185-9. 2011
  9. ncbi request reprint Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines
    Mark H Einstein
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine and Montefiore Medical Center, 1695 Eastchester Rd, Suite 601, Bronx, NY 10461, USA
    Cancer Immunol Immunother 57:443-51. 2008
  10. ncbi request reprint Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer
    Mark H Einstein
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Montefiore Medical Center, Bronx, New York, USA
    Cancer 109:48-53. 2007

Research Grants

Detail Information

Publications58

  1. ncbi request reprint Clinician's guide to human papillomavirus immunology: knowns and unknowns
    Mark H Einstein
    Division of Gynecologic Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA
    Lancet Infect Dis 9:347-56. 2009
    ..However, despite our growing understanding, many aspects of the interactions between HPV and the host immune system remain unknown, and this Review draws attention to several of these unresolved issues and their implications...
  2. pmc Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy
    Mark H Einstein
    Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York, USA
    J Clin Microbiol 52:2089-95. 2014
    ..0%. hrHPV detection by the Xpert demonstrated excellent clinical performance for identifying women with CIN2+ and CIN3+ that was comparable to that of currently available clinically validated tests. ..
  3. pmc Phase II trial of adjuvant pelvic radiation "sandwiched" between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma
    Mark H Einstein
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Bronx, NY, USA
    Gynecol Oncol 124:21-5. 2012
    ..To evaluate the safety and survival in women treated with adjuvant pelvic radiation "sandwiched" between six cycles of paclitaxel and carboplatin chemotherapy with completely resected UPSC...
  4. pmc Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years
    Mark H Einstein
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
    Hum Vaccin 7:1343-58. 2011
    ..Both vaccines were generally well tolerated. Although an immunological correlate of protection has not been defined, differences in the magnitude of immune response between vaccines may represent determinants of duration of protection...
  5. pmc Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years
    Mark H Einstein
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
    Hum Vaccin 7:1359-73. 2011
    ..Considering the differences in cross-protective efficacy between the two vaccines, the results might provide insights into the underlying mechanism(s) of protection...
  6. ncbi request reprint Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years
    Mark H Einstein
    Montefiore Medical Center, Albert Einstein College of Medicine, Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Bronx, NY, USA
    Hum Vaccin 5:705-19. 2009
    ..Long-term studies evaluating duration of efficacy after vaccination are needed for both vaccines...
  7. pmc Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III
    Mark H Einstein
    Albert Einstein College of Medicine, and Albert Einstein Cancer Center, Bronx, NY 10461, USA
    Gynecol Oncol 106:453-60. 2007
    ..bovis BCG heat shock protein (Hsp65) covalently linked to the entire sequence of HPV 16 E7. This trial was designed to evaluate the efficacy and toxicities of HspE7 in women with CIN III...
  8. doi request reprint Age-stratified performance of the Cervista HPV 16/18 genotyping test in women with ASC-US cytology
    Mark H Einstein
    Albert Einstein College of Medicine and Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, NY 10461, USA
    Cancer Epidemiol Biomarkers Prev 20:1185-9. 2011
    ..The objective of this study was to evaluate the clinical performance of the Cervista HPV 16/18 genotyping test for detection of human papilloma virus (HPV) 16 and 18 in cervical cytology specimens in women stratified by age...
  9. ncbi request reprint Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines
    Mark H Einstein
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine and Montefiore Medical Center, 1695 Eastchester Rd, Suite 601, Bronx, NY 10461, USA
    Cancer Immunol Immunother 57:443-51. 2008
    ..This article reviews the known data regarding natural immune responses to HPV and those developed by prophylactic vaccination...
  10. ncbi request reprint Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer
    Mark H Einstein
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Montefiore Medical Center, Bronx, New York, USA
    Cancer 109:48-53. 2007
    ..This study was designed to test for differences in progression-free survival (PFS) and toxicity between the 2 regimens...
  11. ncbi request reprint Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia
    Mark H Einstein
    Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Int J Cancer 120:55-9. 2007
    ..HPV VLP assays may be useful as an adjunct to HPV DNA testing in a subset of patients that needs to be defined by further studies...
  12. doi request reprint Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology
    Mark H Einstein
    Montefiore Medical Center and Albert Einstein College of Medicine, 1695 Eastchester Road, Bronx, NY 10461, USA
    Gynecol Oncol 118:116-22. 2010
    ..This study evaluated the clinical performance of the Cervista HPV HR and 16/18 genotyping tests for detection of HPV in cervical cytology specimens...
  13. pmc Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma
    Mark H Einstein
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Bronx, NY, USA
    Gynecol Oncol 124:26-30. 2012
    ..This is the first report describing the efficacy and toxicity of adjuvant ifosfamide or ifosfamide plus cisplatin "sandwiched" with RT in patients with surgically staged and completely resected uterine carcinosarcoma...
  14. doi request reprint 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors
    L Stewart Massad
    Division of Gynecologic Oncology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Obstet Gynecol 121:829-46. 2013
    ....
  15. ncbi request reprint Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer
    Akiva P Novetsky
    Albert Einstein College of Medicine, Bronx, NY, USA
    Gynecol Oncol 105:635-40. 2007
    ....
  16. pmc High-grade anal intraepithelial neoplasia among HIV-1-infected men screening for a multicenter clinical trial of a human papillomavirus vaccine
    Timothy Wilkin
    Division of Infectious Diseases, Weill Cornell Medical College, New York, New York 10011, USA
    HIV Clin Trials 14:75-9. 2013
    ..High-grade anal intraepithelial neoplasia (HGAIN) is the precursor lesion to invasive anal cancer. Human papillomavirus (HPV) vaccination holds great promise for preventing anal cancer...
  17. pmc Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia
    Koenraad Van Doorslaer
    Department of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Gynecol Oncol 116:208-12. 2010
    ..The induction of a B-cell response by HspE7 and its association with clinical outcome is unknown, and is the purpose of this study...
  18. pmc Metformin use and endometrial cancer survival
    Nicole S Nevadunsky
    Montefiore Medical Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Bronx, NY, USA Electronic address
    Gynecol Oncol 132:236-40. 2014
    ....
  19. pmc Radioimmunotherapy with an antibody to the HPV16 E6 oncoprotein is effective in an experimental cervical tumor expressing low levels of E6
    Rébécca Phaeton
    Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Albert Einstein Cancer Center, Bronx, NY, USA
    Cancer Biol Ther 10:1041-7. 2010
    ..However, that study opened the question whether radioimmunotherapy can suppress the growth of cervical tumors with low E6 and E7 expression, such as may be seen in patients...
  20. pmc Association of bactericidal activity of genital tract secretions with Escherichia coli colonization in pregnancy
    Jeny P Ghartey
    Department of Obstetrics and Gynecology and Women s Health, Montefiore Medical Center, Bronx, NY, USA
    Am J Obstet Gynecol 207:297.e1-8. 2012
    ..Genital tract secretions exhibit bactericidal activity against Escherichia coli. We hypothesized that this defense may be modulated during pregnancy...
  21. pmc Evaluation of 3 approaches for assessing adherence to vaginal gel application in clinical trials
    Ariane van der Straten
    From the Women s Global Health Imperative, RTI International, San Francisco, CA Center for AIDS Prevention Studies CAPS Department of Medicine, UCSF, San Francisco, CA The Population Council, New York, NY Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY and Albert Einstein Cancer Center, Bronx, NY
    Sex Transm Dis 40:950-6. 2013
    ..Accurate measurement of adherence to product use is an ongoing challenge in microbicide trials...
  22. doi request reprint A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube
    Thomas J Herzog
    Columbia University, NY Presbyterian Medical Center, New York, NY, USA Electronic address
    Gynecol Oncol 132:517-25. 2014
    ..To determine the safety and efficacy of the novel combination of docetaxel, oxaliplatin, and bevacizumab as first-line treatment of advanced cancer of the ovary, peritoneum or fallopian tube after initial debulking surgery...
  23. pmc Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study
    Dennis Yi Shin Kuo
    Montefiore Medical Center Albert Einstein College of Medicine, Suite 601, Bronx, NY 10461, USA
    Gynecol Oncol 116:442-6. 2010
    ..Our objective is to determine the efficacy and toxicity of paclitaxel and oxaliplatin in patients with recurrent or metastatic cervical cancer...
  24. pmc Outcomes after an excisional procedure for cervical intraepithelial neoplasia in HIV-infected women
    Laura L Reimers
    Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine and Montefiore Medical Center, 1300 Morris Park Avenue, Belfer Educational Center, Room 501, Bronx, NY 10461, USA
    Gynecol Oncol 119:92-7. 2010
    ..To determine predictors of treatment failure and recurrence after surgical excisional procedures for CIN in HIV-infected women...
  25. ncbi request reprint Obesity and age at diagnosis of endometrial cancer
    Nicole S Nevadunsky
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Montefiore Medical Center, and Albert Einstein Cancer Center and Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York
    Obstet Gynecol 124:300-6. 2014
    ..We hypothesized that obesity might also be associated with an earlier age at endometrial cancer diagnosis, because mechanisms that drive the obesity-endometrial cancer association might also accelerate tumorigenesis...
  26. doi request reprint A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers
    Divya Gupta
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10461, USA
    Gynecol Oncol 113:327-30. 2009
    ..A phase II trial designed to evaluate the safety and efficacy of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine or epithelial ovarian cancers...
  27. pmc Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma
    Gloria S Huang
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10461, USA
    Gynecol Oncol 107:513-7. 2007
    ..The purpose of this study was to determine the clinical utility of CA125 measurement in patients with uterine carcinosarcoma (CS)...
  28. pmc Risk factors for persistent cervical intraepithelial neoplasia grades 1 and 2: managed by watchful waiting
    Gloria Y F Ho
    Departments of Epidemiology and Population Health, Albert Einstein College of Medicine, NY, USA
    J Low Genit Tract Dis 15:268-75. 2011
    ..This study examines risk factors for persistent cervical intraepithelial neoplasia (CIN) and examines whether human papillomavirus (HPV) testing predicts persistent lesions...
  29. pmc Histopathologic differences account for racial disparity in uterine cancer survival
    DAVID SMOTKIN
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Bronx, NY, USA
    Gynecol Oncol 127:616-9. 2012
    ..Reasons for the higher mortality among black women are not completely understood. The aim of our study is to examine the relationship between race/ethnicity, histopathologic subtype, and survival in uterine cancer...
  30. doi request reprint Genetic variants in TAP are associated with high-grade cervical neoplasia
    Mark H Einstein
    Albert Einstein College of Medicine, Bronx, New York, USA
    Clin Cancer Res 15:1019-23. 2009
    ..Consistent with heterogeneity in MHC expression is the individual variability in clearing detectable HPV infections. Genetic polymorphisms in TAP genes may affect protein structure, function, and the ability to clear HPV infection...
  31. pmc Cervical intraepithelial neoplasia is associated with genital tract mucosal inflammation
    Mohak Mhatre
    Departments of Pediatrics, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA
    Sex Transm Dis 39:591-7. 2012
    ..We hypothesize that women with cervical intraepithelial neoplasia (CIN) will exhibit changes in soluble mucosal immunity that may promote HPV persistence and facilitate HIV infection...
  32. doi request reprint High prevalence of high grade anal intraepithelial neoplasia in HIV-infected women screened for anal cancer
    June Y Hou
    Department of Obstetrics and Gynecology and Women s Health, Montefiore Medical Center, Bronx, NY 10461, USA
    J Acquir Immune Defic Syndr 60:169-72. 2012
    ..Women with poorly controlled HIV were significantly more likely to have high-grade AIN (P = 0.03). Given the high rate of AIN in screened HIV-infected women, routine AC screening in all HIV-infected women should be strongly considered...
  33. doi request reprint How does public policy impact cervical screening and vaccination strategies?
    Thomas J Herzog
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Gynecol Oncol 119:175-80. 2010
    ..To examine the current approaches to cervical screening and points to consider for improving HPV vaccination acceptance and uptake in the US...
  34. ncbi request reprint Human papillomavirus and cervical neoplasia
    Mark H Einstein
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine Montefiore Medical Center, Bronx, New York, USA
    Cancer Invest 20:1080-5. 2002
    ..The low rate of HPV-negative cancers implies an effective HPV vaccine might have the ability to eradicate cervical cancer worldwide...
  35. ncbi request reprint Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors
    Gloria S Huang
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA
    Am J Obstet Gynecol 196:243.e1-5. 2007
    ..This study was undertaken to evaluate the ability of preoperative endometrial sampling to accurately diagnose high-grade endometrial tumors...
  36. ncbi request reprint Issues in cervical cancer incidence and treatment in HIV
    Mark H Einstein
    Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, Bronx, New York, USA
    Curr Opin Oncol 22:449-55. 2010
    ..This review discusses the multiple issues surrounding HIV-associated cervical cancer. Also, the unique treatment-related issues in HIV-associated cervical cancer are addressed...
  37. ncbi request reprint Vaccine strategies for human papillomavirus-associated cancers
    Anna S Kadish
    Departments of Pathology, Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, 1695 Eastchester Road, Suite 601, Bronx, NY 10461, USA
    Curr Opin Oncol 17:456-61. 2005
    ..To review novel immunologic strategies for the prevention and treatment of human papillomavirus infection and associated diseases. Both animal model systems and human protocols are discussed...
  38. ncbi request reprint Anogenital neoplasia in AIDS
    Mark H Einstein
    Albert Einstein College of Medicine, Bronx, New York 10461, USA
    Curr Opin Oncol 16:455-62. 2004
    ..We review the recent literature on anogenital neoplasms in AIDS, with emphasis on cancers associated with HPV infection. Immune reactivity to HPV as well as novel immunotherapeutic and preventative strategies are discussed...
  39. pmc A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer
    Marc J Gunter
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA
    Cancer Epidemiol Biomarkers Prev 17:921-9. 2008
    ..Free IGF-I levels were inversely associated with endometrioid adenocarcinoma, consistent with prior cross-sectional data...
  40. ncbi request reprint Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old woman
    Mark H Einstein
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine Montefiore Medical Center, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Clin Cancer Res 8:549-54. 2002
    ..The purpose of our study was to characterize a human papillomavirus (HPV) 16 DNA integration in the genome of a rapidly progressive, lethal cervical cancer in a 39-year-old woman...
  41. doi request reprint 20. Utility of human papillomavirus (HPV) 16 E6 and L1 DNA levels for anal cancer screening in HIV-infected individuals
    Doreen Lee
    Montefiore Medical Center and Albert Einstein School of Medicine, NY, USA
    Sex Health 10:580. 2013
    ..Further studies evaluating the sample yields should be performed to assist in implementation of anal cancer screening programs in defined populations of at-risk individuals. ..
  42. pmc Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive
    Marla J Keller
    Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States of America
    PLoS ONE 7:e46901. 2012
    ..This study was designed to evaluate the safety of vaginal dosing and effects of Acidform on mucosal immune mediators, antimicrobial properties of genital secretions, and vaginal microbiota...
  43. ncbi request reprint A multidisciplinary approach to fertility-sparing therapy for a rare vulvar tumor
    Cary L Dicken
    Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Bronx, New York, USA
    Fertil Steril 93:267.e5-7. 2010
    ..Case report of a young woman with a rare vulvar malignancy who received treatment with a personalized multidisciplinary approach to balance management of her malignancy without compromising survival with her desire for future pregnancy...
  44. pmc The influence of proteasome inhibitor MG132, external radiation, and unlabeled antibody on the tumor uptake and biodistribution of (188)re-labeled anti-E6 C1P5 antibody in cervical cancer in mice
    Rébécca Phaeton
    Department of Obstetrics and Gynecology and Women s Health, Division of Gynecologic Oncology, Albert Einstein College of Medicine, Albert Einstein Cancer Center, Bronx, NY 10461, USA
    Cancer 116:1067-74. 2010
    ..They hypothesized that the pretreatment of tumor cells with various agents that cause cell death and/or elevation of E6 levels would increase the accumulation of radiolabeled antibodies to E6 in cervical tumors...
  45. ncbi request reprint Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003)
    Gary L Goldberg
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA
    Gynecol Oncol 101:261-8. 2006
    ..To review the trends, modifications and results of 103 consecutive total pelvic exenterations (TPE) performed at the Montefiore Medical Center and Albert Einstein College of Medicine from 1987 to 2003...
  46. pmc Performance of implementing guideline-driven cervical cancer screening measures in an inner-city hospital system
    Daryl L Wieland
    Department of Obstetrics and Gynecology, Jacobi Medical Center Bronx, NY, USA
    J Low Genit Tract Dis 15:296-302. 2011
    ..We report the prospective performance of a comprehensive tracking, evidence-based algorithmically driven call back, and appointment scheduling system for cervical cancer screening in a resource-limited inner-city population...
  47. ncbi request reprint Arteriovenous malformations of the uterus: long-term follow-up
    Peer Dar
    Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA
    Gynecol Obstet Invest 66:157-61. 2008
    ..The purpose of this study was to describe our experience with diagnosis, management and long-term follow-up of cases with different clinical presentations of uterine AVMs...
  48. pmc Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men
    Timothy Wilkin
    Division of Infectious Diseases, Weill Cornell Medical College, Montefiore Medical Center, New York, New York, USA
    J Infect Dis 202:1246-53. 2010
    ..Human immunodeficiency virus type 1 (HIV-1)-infected men are at increased risk for anal cancer. Human papillomavirus (HPV) vaccination may prevent anal cancer caused by vaccine types...
  49. doi request reprint Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
    Thomas J Herzog
    Columbia University, New York, NY, USA
    Gynecol Oncol 132:8-17. 2014
    ..To explore the value of multiple clinical endpoints in the unique setting of ovarian cancer...
  50. pmc Use of the dye stain assay and ultraviolet light test for assessing vaginal insertion of placebo-filled applicators before and after sex
    Marla J Keller
    From the Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY The Population Council, New York, NY Albert Einstein Cancer Center, Bronx, NY and National Cancer Institute, National Institutes of Health, Bethesda, MD
    Sex Transm Dis 40:939-43. 2013
    ..This study was designed to determine if semen or presex gel dosing impacts the sensitivity and specificity of a dye stain assay (DSA) for measuring vaginal insertion of placebo-filled applicators with BAT-24 dosing...
  51. doi request reprint 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors
    L Stewart Massad
    Division of Gynecologic Oncology, Washington University School of Medicine, 4911 Barnes Jewish Hospital Plaza, St Louis, MO, USA
    J Low Genit Tract Dis 17:S1-S27. 2013
    ....
  52. ncbi request reprint Cervical intraepithelial neoplasia: an overview of diagnosis and management
    Mark D Levie
    Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine Montefiore Medical Center, Bronx, New York, USA
    Cancer Invest 20:769-76. 2002
  53. ncbi request reprint Uterine artery embolization in the management of vaginal bleeding from cervical pregnancy: a case series
    Jonathan J Trambert
    Department of Radiology, Montefiore Medical Center and Albert Einstein College of Medicine, New York, New York, USA
    J Reprod Med 50:844-50. 2005
    ..To report our experience of selective embolotherapy in 8 consecutive patients with cervical pregnancy (CxP) presenting with vaginal bleeding...
  54. ncbi request reprint What is the role of HPV typing in the United States now and in the next five years in a vaccinated population?
    Warner Huh
    Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
    Gynecol Oncol 117:481-5. 2010
    ..To review the current state of HPV typing of the vaccinated population in the United States and potential for typing of this population over the next 5 years...
  55. ncbi request reprint Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas
    Q Jackie Cao
    Department of Pathology, Albert Einstein College of Medicine and Jack D Weiler Hospital of Montefiore Medical Center, Bronx, New York 10461, USA
    Int J Gynecol Pathol 21:147-54. 2002
    ....
  56. ncbi request reprint Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC)
    Abbie L Fields
    Virginia Gynecologic Oncology, 7603 Forest Avenue, Suite 207, Richmond, VA 23229, USA
    Gynecol Oncol 108:201-6. 2008
    ....
  57. ncbi request reprint Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists
    Yvonne Collins
    University of Illinois, Chicago, IL, USA
    Gynecol Oncol 102:552-62. 2006
    ..This article is intended to provide gynecologic oncologists with a comprehensive background in modern cervical cancer prevention strategies...
  58. ncbi request reprint American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors
    Debbie Saslow
    Cancer Control Science Department, American Cancer Society, Altanta, GA, USA
    CA Cancer J Clin 57:7-28. 2007
    ..They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed...

Research Grants1

  1. Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
    Mark H Einstein; Fiscal Year: 2010
    ..Decreasing HPV rates would have a significant impact on reducing persistent HPV infection, abnormal Pap tests, and cervical cancer nationally and worldwide. ..